期刊文献+

儿童与成人系统性红斑狼疮的临床和免疫学特征比较 被引量:4

Comparison of Clinical and Immunologic Features between Children and Adult Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的探讨儿童与成人系统性红斑狼疮(systemic lupus erythematosus,SLE)的首发临床表现和免疫学特征的区别。方法回顾性分析2002年6月—2007年6月湘雅医院住院诊治的49例儿童SLE(儿童组)的首发症状和免疫学特征,并与同期收治的50例成人SLE(成人组)进行比较。结果与成人组相比,儿童组SLE发病至确诊的时间更长,疾病活动度更高,消化系统受累和淋巴结增大等表现更多见,抗双链DNA抗体(AdsDNA)和抗核糖体P蛋白抗体(ARPA)的阳性率更高,差异均有统计学意义(P均<0.05)。结论与成人SLE相比,儿童SLE更容易误诊,而且疾病活动度更高。提示正确认识儿童SLE的临床和免疫学特点,及早诊治对改善预后有重要意义。 Objective To explore the differences of first clinical and immunologic features between children and adult patients with SLE.Methods A retrospective analysis was conducted on clinical data of 99 patients with SLE(50 adults,49 children) collected during June 2002 and June 2007.The differences of the first clinical and immunologic features between children with SLE(children group) and adult patients with SLE(adult group) were compared.Results Pediatric SLE was more prone to be misdiagnosed and had a higher disease activity,when compared with that of adults with SLE;digestive system symptoms,lymphadenectasis,positive anti-dsDNA antibody(AdsDNA) and anti-ribosomes P-protein antibody(ARPA) were found with significant difference in pediatric SLE(P0.05).Conclusion Pediatric SLE is prone to be misdiagnosed when compared with that of adults with SLE and disease activity is higher than that of adults with SLE.Clinicians should improve awareness of the clinical and immunological characteristics of child patients with systemic lupus erythematosus,which is significant in early diagnosis,treatment and prognosis.
出处 《临床误诊误治》 2012年第10期64-66,共3页 Clinical Misdiagnosis & Mistherapy
基金 国家自然科学青年基金(30900588)
关键词 红斑狼疮 系统性 儿童 成年人 疾病特征 免疫学 Erythematous lupus systematicness Child Adult Disease attribute Immunology
  • 相关文献

参考文献17

  • 1Huang J L, Yeh K W, Yao T C, et al. Pediatric lupus in Asia [ J ]. Lupus, 2010,19 (12) : 1414-1418.
  • 2Kamphuis S, Silverman E D. Prevalence and burden of pedi- atric-onset systemic lupus erythematosus [ J ]. Nat Rev Rheu-matol, 2010,6(9) :538-546.
  • 3Hoehberg M C. Updating the American College of Rheuma- tology revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1997,40 (9) : 1725.
  • 4Bombardier C, Gladman D D, Urowitz M B, et al. Deriva- tion of the SLEDAI. A disease activity index for lupus pa- tients. The committee on prognosis studies in SLE [ J ]. Ar- thritis Rheum, 1992,35:630-640.
  • 5方湘玲,易著文,黄丹琳.儿童系统性红斑狼疮35例[J].实用儿科临床杂志,2004,19(1):55-56. 被引量:8
  • 6Tucker L B. Controversies and advances in the management of systemic lupus erythematosus in children and adolescents [J]. Best Pract Res Clin Rheumatol, 2002,16(3):471-480.
  • 7Brunner H I. Difference in disease features between child- hood-onset and adult-onset systemic lupus erythematosus [ J ]. Arthritis Rheum, 2008,58 (2) :556-562.
  • 8费允云,张奉春.系统性红斑狼疮患者死亡原因分析[J].中华风湿病学杂志,2008,12(3):187-191. 被引量:33
  • 9Richer O, Ulinski T, Lemelle I, et al. Abdominal manifes- tations in childhood-onset systemic lupus erythematosus [ J ]. Ann Rheum Dis, 2007,66(2) :174-178.
  • 10韩咏梅,张新华,李永伟,朱红,徐立勤,孙德本.多发淋巴结肿大的结缔组织疾病26例误诊分析[J].中国实用内科杂志,2006,26(6):867-868. 被引量:5

二级参考文献31

  • 1李颖,张修礼.全身性淋巴结肿大误诊1例分析[J].中国实用内科杂志,2004,24(9):569-569. 被引量:1
  • 2吴凤岐,何晓琥,马松春,陈燕.儿童狼疮脑病39例报告[J].中华儿科杂志,1996,34(4):240-242. 被引量:10
  • 3Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina: a muhicenter study Lupus, 2000, 9: 377-381.
  • 4Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus (Part 1 ): entry variables as predictors of prognosis. Arthritis Rheum, 1982, 25: 601-611.
  • 5Abu-Shakra M, IJrowitz MB, Gladman DD, et al. Mortality study in systemic lupus erythematosus, Results from a single center. 1. Causes of death. J Rheumatol, 1995, 22: 1259-1264.
  • 6Abu-Shakra M, Gladman DD, IJrowitz MB, et al. Mortality stud- ies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev, 2004, 3: 418-420.
  • 7Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore), 2003, 82: 299-308.
  • 8Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol, 2001, 13: 345-351.
  • 9Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1000 patients. Medicine (Baltimore), 1999, 78: 167-175.
  • 10Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of deaths of 513 Danish patients with systemic lupus erythematosus, Scand J Rheumatoi, 1999, 28: 75-80.

共引文献45

同被引文献37

  • 1姚冬云,宋庆林,李文永,慕晓霞,李建平.以AITP为首发表现的系统性红斑狼疮33例分析[J].中国误诊学杂志,2004,4(7):1114-1115. 被引量:2
  • 2仲人前,耿红莲.自身免疫性疾病实验室诊断进展[J].中华检验医学杂志,2005,28(8):867-869. 被引量:32
  • 3滕庆,何晓琥,李彩凤.狼疮抗凝集物检测在系统性红斑狼疮、原发性血小板减少症中的临床应用[J].实用儿科临床杂志,2005,20(6):559-560. 被引量:1
  • 4Pratt EL, Tarantino MD, Wagner D, et al. Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thromboeytopenie purpura [ J ]. Am J Hematol, 2005,79 (3) :175-179.
  • 5Fabiana de Miranda Moura dos Santos,Mariane CuradoBorges, Rosa Weiss Telles,et al. Excess weight and as-sociated risk factors in patients with systemic lupus ery-thematosus[J]. Rheumatol Int,2012,33(3):681-688.
  • 6RJ Davies, MCE Lomer, SI Yeo, et al. Weight loss andimprovements in fatigue in systemic lupus erythematosus:a controlled trial of a lowg lycaemic index diet versus acalorie restricted diet in patients treated with corticos-teroids[J]. Lupus,2012,21(6): 649-655.
  • 7Cox JH, Starr AE, Kappelhoff R, et al. Matrix metallo-proteinase 8 deficiency in mice exacerbates inflammatoryarthritis through delayed neutrophil apoptosis and re-duced caspase 11 expression [J]. Arthritis Rheum, 2010,62(12): 3645-3655.
  • 8B Manaboriboonl, ED Silverman2, M Homsanit,et al.Weight change associated with corticosteroid therapy inadolescents with systemic lupus erythematosus [J]. Lupus,2013,22(2):164-170.
  • 9Li-Fei Hou, Shi-Jun He, Xin Li, et al. Oral Administra-tion of Artemisinin Analog SM934 Ameliorates LupusSyndromes in MRL/lpr Mice by Inhibiting Thl and Thl7 Cell Responses[J]. ARTHRITIS & RHEUMATISM,2011,63(8):2445-2455.
  • 10Feng J B,Ni J D,Yao X,et al.Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus:1790 cases[J].Rheumatol Int,2010,30(8):1017-1023.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部